Hydroxyurea and Primary myelofibrosis - a phase IV clinical study of FDA data

Summary:

Primary myelofibrosis is found among people who take Hydroxyurea, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Hydroxyurea and have Primary myelofibrosis. It is created by eHealthMe based on reports of 13,652 people who have side effects when taking Hydroxyurea from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 22, 2023

13,652 people reported to have side effects when taking Hydroxyurea.
Among them, 141 people (1.03%) have Primary myelofibrosis.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 13,923 Hydroxyurea users for its effectiveness, alternative drugs and more.

What is Primary myelofibrosis?

Primary myelofibrosis (primary disorder of the bone marrow) is found to be associated with 1,090 drugs and 769 conditions by eHealthMe.

Number of Hydroxyurea and Primary myelofibrosis reports submitted per year:

Could Hydroxyurea cause Primary myelofibrosis?

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyurea and have Primary myelofibrosis?

Check whether Primary myelofibrosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Primary myelofibrosis and when was it recovered:

Primary myelofibrosis in Hydroxyurea

Expand to all the drugs that have ingredients of hydroxyurea:

Primary myelofibrosis and drugs with ingredients of hydroxyurea (397 reports)

Alternative drugs to, pros and cons of Hydroxyurea:

Hydroxyurea (13,923 reports)

Common Hydroxyurea side effects:

Fatigue (feeling of tiredness): 1,423 reports
Diarrhea: 1,237 reports
Headache (pain in head): 981 reports
Thrombocytopenia (decrease of platelets in blood): 892 reports
Weakness: 794 reports
Fever: 786 reports
Pain: 754 reports

Browse all side effects of Hydroxyurea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Primary myelofibrosis treatments and more:

Primary myelofibrosis (35,056 reports)

COVID vaccines that are related to Primary myelofibrosis:

Common drugs associated with Primary myelofibrosis:

All the drugs that are associated with Primary myelofibrosis:

Primary myelofibrosis (1,090 drugs)

Common conditions associated with Primary myelofibrosis:

High blood pressure: 141 reports
Idiopathic thrombocytopenic purpura (itp): 108 reports

All the conditions that are associated with Primary myelofibrosis:

Primary myelofibrosis (769 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydroxyurea (the active ingredients of Hydroxyurea) and Hydroxyurea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.